In contrast to the inhibitors of kynurenine and PGE2 synthesis, neutralization of TGFβ had no effect on the anti-proliferative activity of untreated and TI-treated HD/ASCs, SLE/ASCs, and SSc/ASCs (Figure 8). Here, TGFB1 is linked to systemic sclerosis.